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Panretinal photocoagulation (P RP) has greatly improved the prognosis for patients with proliferative diabetic ret inopathy. While most patients tolerate PRP well under Eye (1993) 7, 768-771 topical anaesthesia alone, there are a significant number of patients who experience discomfort and pain. The alter native for these patients involves either retrobulbar, per ibulbar or subconjunctival injection, or general anaesthesia. The local anaesthetic techniques use a sharp, or relatively sharp, needle which for the retrobulbar and peribulbar techniques is 'blindly' placed into the orbit to deliver the anaesthetic solution. Sharp needle sub-Tenon injection 10 mm posterior to the limbus in the quadrant for photocoagulation has been reported as providing good anaesthesia for PRE i It is useful if sector photocoag ulation is required, but would involve multiple quadrant delivery if PRP is to be performed.
Deep introduction of a sharp needle m a y rarely cause damage to orbital structures, including perforation of the globe, 2 a blood vessel or the optic nerve sheath, and anaes thetic may perfuse into the subarachnoid space causing respiratory or cardiovascular arrest. 3 For these reasons, sharp needle local anaesthetic blocks should be admin istered where full resuscitation facilities are available.
Friedberg and Palmer 4 reported a single-quadrant, sub Tenon anaesthetic technique, involving irrigation of local anaesthetic solution to the superior-nasal quadrant of pos terior Tenon's space. They performed PRP to 40 eyes and questioned patients regarding pain but did not perform visual analogue pain scoring. Friedberg and Palmer reported access to the superior-nasal quadrant as being difficult in anxious patients due to Bell's phenomenon, and in these patients the inferior-nasal quadrant was chosen. Another technique of sub-Tenon delivery which has been shown to be well tolerated when used for cataract extraction specifically uses the inferior-nasal quadrant. s This sub-Tenon technique is similar to that of Friedberg and Palmer 4 but differs in not involving a subconjunctival injection using a sharp needle and also delivery of anaes thetic is to the inferior-nasal quadrant in all patients. Use of sub-Tenon delivery with a low volume «3 ml) avoids complications associated with a large volume of local anaesthetic agent such as a tight orbit, 6 raised intraocular pressure 7 and systemic absorption with possible toxicity.
We describe the use and evaluation of patient tolerance of this infero-nasal one-quadrant technique for PRP for treatment of proliferative diabetic retinopathy in an out patient setting.
MATERIALS AND METHODS
Twelve patients (4 men and 8 women) aged from 18 years to 56 years with proliferative diabetic retinopathy who were to receive PRP had a local anaesthetic block by one quadrant sub-Tenon irrigation. All had expressed anxiety about discomfort experienced during a previous treatment episode. Each had received previous PRP using topical anaesthesia of amethocaine 1 %. Further treatment was necessary, all patients having active new vessels on fundal examination.
One-Quadrant Sub-Tenon Technique
After informed consent, the pupil is dilated using four drops of cyclopentolate 1 % and prophylactic chloram phenicol 0.5% is applied to the inferior conjunctival for nix. Two drops of amethocaine 1 % are administered to the inferior conjunctival fornix. The one-quadrant sub-Tenon technique used has been previously published 5 and the method used for PRP is summarised below. The patient lies down and is asked to look upward and outward with respect to the eye to be anaesthetised, expos ing the infero-temporal bulbar conjunctiva without the need for a lid speculum. A small fold of bulbar con junctiva is grasped with Moorfields forceps or similar, and a 'nick' incision made in the conjunctiva using blunt tipped Westcott's spring scissors. A new blunt-tipped, purpose-designed, curved 19-swg irrigating cannula S is then used to deliver a small quantity of local anaesthetic just sufficient to raise a small bleb of conjunctiva. This elevation of conjunctiva facilitates identification of Tenon's fascia, which appears as opaque and whitish tis sue. The Westcott scissors are then reintroduced through the previous incision in the conjunctiva and used to create another 'nick' in Tenon's fascia. Moorfields forceps are used to grip the conjunctival edge where the small nick was made and the blunt curved cannula is then inserted onto bare sclera and glided along a path following the con tour of the globe, until just posterior to the equator. It is very important to pass through conjunctiva and Tenon's fascia to reach bare sclera, and therefore into Tenon's space, before sliding the cannula posteriorly. Gentle pres sure is applied to the syringe and after a few seconds a slight 'give' is felt, solution begins to flow and the cannula may be further advanced to a position immediately pos terior to the equator of the globe. After delivery of approximately 1.5-2 ml of plain lignocaine 2% anaes thetic solution, the cannula is withdrawn. At least 5 min utes is allowed for diffusion to occur before commencing treatment. After PRP treatment is completed, a course of topical chloramphenicol four times daily for 1 week is pre scribed. This is to provide prophylactic antibiotic cover for the incision to conjunctiva and Tenon's fascia.
P anretinal Photocoagulation
Laser application was with a Coherent argon laser, using argon green, 515 nm wavelength and applied using a Yolk TransEquator 9 fundus contact lens. A constant spot size of 500 11m was used throughout. The laser spot duration time was 0.1-0.15 seconds, with the exception of one patient who had treatment of 0.4 seconds duration. This was due to the presence of a dense vitreous haemorrhage requiring increased energy delivery. The energy used was 280-1000 mW (mean 529 mW).
Pain Score Assessment
Each patient was shown a 10 cm, visual analogue pain score chart with numerical and descriptive rating scale, graded from 0 to 10. 5 Patients were shown the chart, by Pain Scores one investigator only, after completion of the PRP treat ment and invited to score where on the chart they would grade any discomfort or pain experienced. If unable to see the chart, or read the accompanying text (printed at NlO size), a verbal explanation and description of the scoring chart was performed.
RESULTS
The results of the patient pain scores are presented graphically in Fig. 1 . The pain experienced during the pre vious treatment episode when PRP was performed with topical amethocaine 1 % alone, was graded as median 8, mean 8.5 with a range of 6-10. The administration of the sub-Tenon anaesthesia was well tolerated with a median pain score of 1.5, mean 1.9 and range 0-5.
PRP after sub-Tenon administration was tolerated by 11 of the 12 patients with a median of 1.5, mean 1.8 and range of 0-9. The range was wide due to one patient with a high pain score who was intolerant of PRP in spite of the sub Tenon delivery.
Sub-Tenon irrigation allowed 11 of 12 previously intol erant patients to complete a PRP treatment episode. Com parison of pain scores demonstrates significantly better anaesthesia with sub-Tenon irrigation than topical treat ment alone (p<0.005, Wilcoxon ranked sign test). Fig. 2 plots the PRP pain scores for each of the 12 patients for topical anaesthesia and after sub-Tenon anaesthesia. All but one patient scored sub-Tenon anaesthesia as 0-3 on the chart, indicating that PRP is well tolerated by these patients. One patient (no. 7) scored 2 for the delivery of the sub-Tenon anaesthesia and 9 for the delivery of the PRP. The sub-Tenon delivery appeared to have no anaes thetic effect in this instance. This patient requested an alternative form of anaesthesia for future treatment epi sodes; the remaining 11 patients indicated that they would prefer sub-Tenon anaesthesia to topical anaesthesia if future PRP were required. All 12 patients developed a subconjunctival haemor rhage occupying one or two quadrants of the bulbar con junctiva and mild chemosis in the infero-nasal quadrant. Two patients developed marked ocular pain with nausea and vomiting 4 hours after administration of the anaes thetic and laser treatment which settled over the course of the same day. This coincided with the recovery of ocular sensation as the effect of the plain lignocaine 2% sub sided. Neither patient had a rise in intraocular pressure.
Patient no. 7 was the one patient who experienced significant pain and had only 293 burns before PRP treat ment was terminated. Patient no. 3 received only 361 burns due to a poor view from vitreous haemorrhage. The other 10 patients received an average of 690 burns (range 480-1204).
DISCUSSION
Possible sources of bias in the study design are that the patients offered sub-Tenon anaesthesia are a small group (n = 12) selected to be intolerant of PRP under topical anaesthesia and that the pain of PRP performed at the treatment session was compared with that of a previous session from long-term memory. The patient group may also have a different response to pain from PRP delivery or be less tolerant of a painful stimulus than an otherwise 9 10 11 12
Topical Anaesthesia Sub-Tenon Anaesthesia random group of patients. It may be that any alternative local anaesthetic technique to that used previously may be graded as 'better' and any 'extra' anaesthesia offered may have a powerful placebo effect. For this reason bias against topical amethocaine 1 % alone may be present. Within these limitations the study was designed, however, to select these 'worse case' patients for sub-Tenon anaes thesia. Toleration and completion of a PRP episode may itself be an outcome measure of success. PRP after sub Tenon administration was well tolerated by 11 of the 12 patients and the median pain score of 1.5 for both the administration of the block and the PRP is very low. The pain score results for the giving of sub-Tenon irrigation (median 1.5, mean 1.9) compare with previously reported scores (median 1.0, mean 1.0) for a cohort of patients undergoing cataract extraction using the same sub-Tenon technique. s
The one patient who did not have sufficient anaesthesia by the sub-Tenon block requested termination of the PRP treatment session. The patient did not wish to continue PRP treatment at that session and therefore no 'top-up' of further anaesthetic solution was administered. An advan tage of the sub-Tenon technique over injectable methods is that once the track beneath Tenon's capsule has been created, it is relatively easy to deliver further solution.
Two patients had significant pain 4 hours after treat ment, providing further evidence that sub-Tenon anaes thesia had an anaesthetic effect. This pain experienced after 4 hours was a deep, aching discomfort and was not associated with the small incision in the conjunctiva since it was not associated with blinking and resolved later. To prevent post-treatment pain a longer-acting local anaes thetic combination may be used, such as a 50:50 mixture of 2% lignocaine with 0.5% bupivacaine. This is the com bination used for cataract surgery involving the one-quad rant sub-Tenon technique S and this longer duration mixture may be more appropriate for use with PRP than lignocaine 2% alone. Hyaluronidase was not used due to difficulties with supply, and the effects of its use with sub Tenon delivery are unknown. Adrenaline is not added to the anaesthetic agent due to the unknown effects of appli cation of adrenaline to the posterior sub-Tenon space, where vasospasm may be expected to occur.
To compare directly the effect of sub-Tenon anaesthesia with topical treatment would involve a randomised trial of sub-Tenon anaesthesia versus topical treatment for patients who had not experienced PRP previously. Many patients experience only mild discomfort with PRP and it may not be justified to perform an invasive local anaes thetic procedure routinely. The risk-benefit ratio of any local anaesthetic technique must be considered. Though blunt cannula sub-Tenon anaesthesia seeks to avoid the risks of sharp needle techniques, it remains an invasive procedure with an incision into conjunctiva and Tenon's fascia. Some subconjunctival haemorrhage occurred in all patients, though this was not problematic since all patients were advised of this, prior to administration of the block.
If a patient tolerates PRP with simple topical anaes thesia then this is our method of choice, though if pain is experienced, further anaesthesia should be administered. If a single quadrant is to be treated, subconjunctival anaes thesia has been reported to be effective, 1 though the one quadrant sub-Tenon technique offers an alternative. Use of plain lignocaine 2% can deliver anaesthesia for the PRP procedure but may provide insufficient post-treatment anaesthesia, and use of a longer-acting agent such as bupi vacaine 0.5% should be considered. IfPRP is required and intolerance of laser application requires additional anaes thesia, then the one-quadrant sub-Tenon technique can provide effective anaesthesia with the benefit of seeking to avoid the risks of sharp needle techniques.
